80 related articles for article (PubMed ID: 12632078)
1. Splicing variant DeltaVII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells.
Ballschmieter P; Braig M; Lindemann RK; Nordheim A; Dittmer J
Int J Oncol; 2003 Apr; 22(4):849-53. PubMed ID: 12632078
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.
Lindemann RK; Braig M; Ballschmieter P; Guise TA; Nordheim A; Dittmer J
Int J Oncol; 2003 Apr; 22(4):799-805. PubMed ID: 12632071
[TBL] [Abstract][Full Text] [Related]
3. Importance of ets1 proto-oncogene for breast cancer progression.
Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
[TBL] [Abstract][Full Text] [Related]
4. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
5. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
6. A variant form of ETS1 induces apoptosis in human colon cancer cells.
Huang CC; Papas TS; Bhat NK
Oncogene; 1997 Aug; 15(7):851-6. PubMed ID: 9266972
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Ets1 is an effector of protein kinase Calpha in cancer cells.
Vetter M; Blumenthal SG; Lindemann RK; Manns J; Wesselborg S; Thomssen C; Dittmer J
Oncogene; 2005 Jan; 24(4):650-61. PubMed ID: 15531915
[TBL] [Abstract][Full Text] [Related]
9. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
Li R; Pei H; Watson DK; Papas TS
Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
[TBL] [Abstract][Full Text] [Related]
10. Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion?
Vandenbunder B; Wernert N; Queva C; Desbiens X; Stehelin D
Folia Biol (Praha); 1994; 40(5):301-13. PubMed ID: 7534726
[TBL] [Abstract][Full Text] [Related]
11. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells.
Fafeur V; Tulasne D; Quéva C; Vercamer C; Dimster V; Mattot V; Stéhelin D; Desbiens X; Vandenbunder B
Cell Growth Differ; 1997 Jun; 8(6):655-65. PubMed ID: 9185999
[TBL] [Abstract][Full Text] [Related]
12. Expression of the transcription factor c-Ets1 correlates with the occurrence of invasive processes during normal and pathological development.
Vandenbunder B; Queva C; Desbiens X; Wernert N; Stehelin D
Invasion Metastasis; 1994-1995; 14(1-6):198-209. PubMed ID: 7657513
[TBL] [Abstract][Full Text] [Related]
13. Role of ETS1 in IL-2 gene expression.
Romano-Spica V; Georgiou P; Suzuki H; Papas TS; Bhat NK
J Immunol; 1995 Mar; 154(6):2724-32. PubMed ID: 7876544
[TBL] [Abstract][Full Text] [Related]
14. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
Zhang Y; Yan LX; Wu QN; Du ZM; Chen J; Liao DZ; Huang MY; Hou JH; Wu QL; Zeng MS; Huang WL; Zeng YX; Shao JY
Cancer Res; 2011 May; 71(10):3552-62. PubMed ID: 21444677
[TBL] [Abstract][Full Text] [Related]
15. ERbeta exerts multiple stimulative effects on human breast carcinoma cells.
Hou YF; Yuan ST; Li HC; Wu J; Lu JS; Liu G; Lu LJ; Shen ZZ; Ding J; Shao ZM
Oncogene; 2004 Jul; 23(34):5799-806. PubMed ID: 15208676
[TBL] [Abstract][Full Text] [Related]
16. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.
Raouf A; Li V; Kola I; Watson DK; Seth A
Oncogene; 2000 Apr; 19(15):1969-74. PubMed ID: 10773887
[TBL] [Abstract][Full Text] [Related]
17. Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51.
Laitem C; Leprivier G; Choul-Li S; Begue A; Monte D; Larsimont D; Dumont P; Duterque-Coquillaud M; Aumercier M
Oncogene; 2009 May; 28(20):2087-99. PubMed ID: 19377509
[TBL] [Abstract][Full Text] [Related]
18. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
19. Does a truncated form of the transcription factor Ets1 exist in breast cancer cells?
Dittmer J
Br J Cancer; 2006 Jan; 94(1):176-7. PubMed ID: 16333304
[No Abstract] [Full Text] [Related]
20. [How tumors abuse their host: the transcription factor c-ets1 and the regulation of tumor angiogenesis or invasion].
Vandenbunder B; Wernert N; Stéhelin D
Contracept Fertil Sex; 1994 Oct; 22(10):656-60. PubMed ID: 7528601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
